Company

Champions Oncology, Inc.

Headquarters: Hackensack, NJ, United States

Employees: 194

CEO: Dr. Ronnie Morris M.D.

NASDAQ: CSBR +14.25%

Market Cap

$68.6 Million

USD as of July 1, 2024

Market Cap History

Champions Oncology, Inc. market capitalization over time

Evolution of Champions Oncology, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Champions Oncology, Inc.

Detailed Description

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Top 1-year algo backtest: +177.66%

$10,000 in August 2023 would now be $27,766 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Champions Oncology, Inc. has the following listings and related stock indices.


Stock: NASDAQ: CSBR wb_incandescent

Stock: FSX: 2I3 wb_incandescent

Details

Headquarters:

One University Plaza

Suite 307

Hackensack, NJ 07601

United States

Phone: 201 808 8400